CACNG3 and glioma: Besides, the expression level of CACNG3 was significantly raised in the neural subtype group and reduced in the mesenchymal subtype group (Fig. 3G), suggesting that CACNG3 can predict neural and mesenchymal molecular subtype gliomas, while the latter correlates with a more invasive and treatment-resistant phenotype, indicating poor prognosis in glioma patients.